Introduction {#sec1-1}
============

The genus *Penicillium* is widespread in nature and grows in many different habitats. Most Penicilli are ubiquitous and generally they are saprophytic organisms with significant usage in the industrial mycology for antibiotics (such as penicillin and griseofulvin) and enzymes (such as ribonuclease) production, but they are also known as spoilage agents in the food industry.

*Penicillium roqueforti*, a species especially known for its involvement in silage contaminations, is also commonly involved in the spoilage of hard, semi-hard and soft-cheeses (Filtenborg *et al*., [@ref11]; Kure and Skaar, [@ref24]; Kure *et al*., [@ref25]). However, selected strains of *P. roqueforti* are used in food manufacture and play a decisive role in the ripening of some cheeses, such as Gorgonzola, Roquefort, Stilton and Danablu. Inoculating the milk with pure cultures of *P. roqueforti* is essential to obtain the characteristic flavours and aromas of these cheeses, due to the strong lipolytic activity of the moulds and to the production of short chain fatty acids (acetic, butyric, caprylic, and caproic acid). Fatty acids are oxidised to produce methylketone, which improves flavour (Caridi, [@ref5]; Tiecco, [@ref47]). Typically, in spicy Gorgonzola and blue cheeses production, *P. roqueforti* is used as a unique culture. In sweet Gorgonzola production, *P. glabrum* and *P. crustosum* cultures are used on their own or in association with *P. roqueforti*. The use of different mixtures of Penicilli confers the blue-green marbling characteristics and creaminess of each particular cheese (Finoli *et al*., [@ref12]). However, some species of *Penicillium* can produce toxic metabolites. The toxigenicity of *Penicillium* species is known about since 1913, when penicillic acid was isolated from cultures of *P. puberulum* Bain (Frisvad and Filtemborg, [@ref14]). *P. roqueforti* is known to produce the following toxins: roquefortine C, PR-toxin, patulin, penicillic acid, mycophenolic acid and isofumigaclavine A and B (Frisvad *et al*., [@ref15]; O'Brien *et al*., [@ref31]).

Roquefortine C {#sec1-2}
==============

Roquefortine is an alkaloid with neurotoxic activity that causes paralysis in guinea pigs. Roquefortine has antibacterial properties and is Ames test negative. There are no studies of its toxicity in laboratory animals that meet good laboratory practice standards. Older data suggest roquefortine toxicity (ip) is in the range of 15-100 mg/kg of body weight (Scott, [@ref43]). Arnold *et al*. ([@ref1]) report an oral LD~50~ of 169 mg/kg in male and 184 mg/kg in female CR57 mice and a similar value for male and female Swiss Webster mice. The data on neurotoxicity of roquefortine are equivocal (Fog Nielsen *et al*., [@ref13]). Several studies have revealed the presence of roquefortine C in blue-veined cheeses (Ohmomo *et al*., [@ref33]; Scott and Kennedy, [@ref45]; Ware *et al*., [@ref50]; López-Díaz, [@ref28]). Finoli *et al*. ([@ref12]) reported roquefortine C concentrations ranging from 50 to 1470 µg/kg after analysis of 30 blue-cheeses. Kokkonen *et al*. ([@ref23]) showed that the concentration of this metabolite ranged from 600 to 12,000 µg/kg in 9 blue cheeses.

PR-toxin {#sec2-1}
--------

PR-toxin is one of the metabolites produced by *P. roqueforti* having acute toxicity (Scott, [@ref43]): it is lethal to rats, mice, and cats and is mutagenic in the Ames test (Fog Nielsen *et al*., [@ref13]). In mice, the ip LD~50~ is 5.8 mg/kg (Chen *et al*., [@ref6]). It has often been found in marbled cheeses (Wei *et al*., [@ref51]). Polonelli *et al*. ([@ref35]) speculate that microaerophilic condition prevails in most cheeses, which may explain why the PR-toxin is not generally found in the final product. However, PR-toxin is unstable because it quickly reacts with nitrogen compounds such as ammonia and ammonia salts, amino acids (lysine and cysteine), amines, casein and the decomposition products resulting in a less toxic PR imine (Erdogan *et al*., [@ref10]).

Patulin {#sec2-2}
-------

Patulin is a toxic secondary metabolite produced by certain species of the genera *Aspergillus*, *Penicillium*, and *Byssochlamys*. It is considered neurotoxic, embryotoxic and teratogenic (Dombrink-Kurtzman and Blackburn, [@ref7]) and has been classified by IARC as category 3 *unclassifiable as to carcinogenicity in humans*; the evidence for carcinogenicity of patulin in experimental animals is considered inadequate and the results of genotoxicity tests are non-conclusive (IARC, [@ref18]). The carcinogenic activity in different animal models is still the subject of some controversy (Schumacher *et al*., [@ref42]). The LD~50~ of patulin ranges from 15 to 25 mg/kg and varies with animal species and route of exposure (Yang *et al*., [@ref20]). Few studies on the presence of this mycotoxin in cheese have been published: by Spanish (López-Diaz *et al*., [@ref28]), by Turkish (Erdogan *et al*., [@ref10]) and by Italian researchers (Pattono *et al*., [@ref34]).

Penicillic acid {#sec2-3}
---------------

Penicillic acid is a lactone substance and possesses a wide range of toxic properties including carcinogenicity (Klari Šegvi *et al*., [@ref22]). However, IARC classified penicillic acid as belonging to Group 3, which means that penicillic acid is not carcinogen to humans (IARC, [@ref19]). Studies on experimental animals revealed that penicillic acid induces significant hepatobiliary excretory dysfunction in mouse and rats, while it did not provoke significant damage to internal organs in chickens. The toxin has a LD~50~ of 100 mg/kg by subcutaneous injection in mice (Sansing *et al*., [@ref38]). The production of penicillic acid has been highlighted in two strains out of six selected among fungal isolates from Cheddar cheese starter (Moubasher *et al*., [@ref30]).

Mycophenolic acid {#sec2-4}
-----------------

Mycophenolic acid is a metabolite produced by *P. roqueforti* and other species of *Penicillium* (Lafont *et al*., [@ref26]). Because of its use as a human drug, mycophenolic acid is best understood. It is antibacterial and immunosuppressive in animals: acute toxicity and mutagenic effects have been described for chickens, mice, rats and rabbits (Engel *et al*., [@ref9]; Kajiwara *et al*., [@ref21]). The toxin has a LD~50~ of 450 mg/kg by *e.g.* in rat (Bentley, [@ref2]). Furthermore, it has been found to occur naturally in some blue cheeses and in silage (Fog Nielsen *et al*., [@ref13]). Zambonin *et al*. ([@ref53]) found mycophenolic acid concentrations ranging from 100 to 500 µg/kg in 5 samples of Gorgonzola and Danablu. Usleber *et al*. ([@ref48]) investigated the occurrence of mycophenolic acid in 53 blue-cheeses and found that the levels of this mycotoxin varied from \<10 to 1200 µg/kg for blue-veined cheeses while a blue-white mold cheese contained 11,000 µg/kg.

Isofumigaclavine (A-B) {#sec2-5}
----------------------

Isofumigaclavine A, an alkaloid, and its hydrolysis product, isofumigaclavine B, are identical to Roquefortine A and B, respectively. Most of the physical properties reported for Roquefortine A (Ohmomo *et al*., [@ref33]) are similar to those of isofumigaclavine A and the Authors may be the same compound. However, isofumigaclavine B, obtained by hydrolysis of isofumigaclavine A, had a higher melting point than that reported for Roquefortine B (Scott and Kennedy, [@ref45]). The toxicological effects of these substances are not well known, but some neurotoxic data are described by Ohmomo *et al*. ([@ref33]), Scott ([@ref43]), and Scott *et al*. ([@ref45]). Isofumigaclavine A (average 0.61 μg/g) and traces of Isofumigaclavine B, were found in 16 samples of marbled cheese (Scott *and Kennedy, [@ref45]). A* similar study detected low levels of Isofumigaclavine A and B in blue cheese (O'Connor and O'Brien, [@ref32]). Based on these bibliographic evidence, the aim of this study was to evaluate the potential production of secondary metabolites by fungal starters used in the production of Gorgonzola cheese.

Materials and Methods {#sec1-3}
=====================

The study was conducted on nine industrial batches of five *Penicillium roqueforti* starters used in the production of the Gorgonzola cheese. The batches were all produced by the Centro Sperimentale del Latte S.r.l. \[(Zelo Buon Persico (LO), Italy)\] and were named: PV 11104, NON 11203, PV 10704, NOC 09203, NON 10803, NON 10804, NOPC 09103, NOPC 10902, and PY 10604. The strains composition of each of the five starters (PV, NON, NOC, NOPC, and PY) was characterised by PCR technique (data not shown). The *P. roqueforti* metabolites of interest were: PR toxin, roquefortine C and mycophenolic acid. The research was carried out in three steps. Step A (*in vitro s*tudies), detection of fungal secondary metabolites in laboratory culture medium. Step B (*in vitro* studies), detection of fungal secondary metabolites in samples of industrial culture medium (breadlike), that is on the substrate and in conditions in which the strains of *P. roqueforti* are industrially grown. Step C (*in vivo* studies), detection of fungal secondary metabolites on nine randomised samples of Gorgonzola cheese, produced with the above-mentioned starters and collected after at least 60 days of ripening (i.e. cheese ready to market).

Step A: *in* *vitro* studies on laboratory culture medium {#sec2-6}
---------------------------------------------------------

Following the method suggested by Frisvad and Thrane ([@ref16]), the spores of each fungal strain are spread on eight Petri plates containing CYA (Czapek Yeast Agar; Merck, Darmstadt, Germania) and incubated at 25°C for 14 days, in the dark. The whole contents of the plates were transferred in polyethylene bags and the secondary metabolites were extracted with 150 mL of chloroform-methanol (2:1, v/v) (Merck) in a stomacher for 3 min and filtered through Whatman N° 1 paper. After addition of 1 mL of phosphoric acid (85%) (Merck) and filtration through Whatman N° 1 paper, the fungal cultures were extracted with acetone-ethyl acetate (1:1, v/v) (J.T.Baker Chemicals, Center Valley, PA, USA) and filtered through Whatman N° 1 paper once more by suction. The latter liquid fraction was refiltered through a Whatman 1 PS phase separator filter and the organic phases were evaporated *in vacuum* at 40°C on a rotary evaporator. The residue was taken up in 3 mL of methanol and washing twice with petroleum ether (Merck).

The lower secondary metabolite-containing methanol phase was filtered through disposable filters (0.45 μm) before injection. Several alkylphenones (acetophenone, propiophenone, butyrophenone, hexanophenone, valerophenone, octanophenone, decanophenone; Sigma Aldrich, St. Louis, MO, USA) are used as internal standards and are injected on a 100 mm x 4 mm I.D. Nucleosil 5 μm C~18~ column (Waters Corporation, Milford, MA, USA) of HPLC with diode-arrays detector (Hplc and diode- arrays detector system; Shimadzu, Kyoto, Japan), initially in pure form and then mixed at the fungal extract of each plate. The mobile phases are the same pointed out by Frisvad (Frisvad and Thrane, [@ref16]). All metabolites were detected at 225 nm.

Both for detected alkylphenones and secondary metabolites, the retention index (RI) is calculated from the following equation: where Tsm=retention time of the secondary metabolite, Tp1=retention time of the alkylphenone that elutes before the secondary metabolite, Tp2=retention time of the alkylphenone that elutes after the secondary metabolite, z=number of carbon atoms in the alkylphenone that elutes before the secondary metabolite and Δz=difference between the number of carbon atoms in the alkylphenones that elute before and after the secondary metabolite. All the reagents were Hplc grade. The injections were performed in duplicate.

Step B: *in* *vitro* research on bread substratum {#sec2-7}
-------------------------------------------------

The secondary metabolites are extracted from the bread substratum through the same preceding steps, exploiting the solvents in the same way and using the same alkylphenones.

Step C: *in* *vivo* research {#sec2-8}
----------------------------

The cheese analysis was carried out by specific methods for the detection of the three metabolites, separately processing the same samples three times. The methods are described as follows.

For mycophenolic acid: a 25 g portion of cheese was homogenised with 50 mL of 5% aqueous NaCl in an ultraturrax for 2 min. After addition of 150 mL of methanol-CHCl~3~ (1:1, vol/vol) (Merck), the mixture was homogenised for 3 min and filtered, and the filtrate was stored overnight at -20°C. The precipitated casein was removed by centrifugation (10 min, 5.000xg). The supernatant was evaporated to about 100 mL in a rotary evaporator, quantitatively transferred into a funnel, and extracted three times with 100 mL of n-hexane (Merck) each time. This defatted aqueous phase was consecutively extracted with two 100-mL portions of CHC1~3~, 100 mL of CHCl~3~-ethyl acetate (1:1, vol/vol) (Merck), and finally 100 mL of ethyl acetate. The combined extracts were dried with sodium sulfate (J.T.Baker Chemicals), evaporated to dryness, dissolved in CHCl~3~, transferred quantitatively into a screw-cap vial, evaporated under nitrogen to dryness, and dissolved in 125 μL of CHC1~3~ (Engel *et al*., [@ref9]). For PR-toxin: a 50 g portion of cheese was homogenised with 250 mL of methanol-water (55:45 vol/vol) (Merck) and with 150 mL of hexane (Merck) in an waring blender for 5 min at high speed. The obtain emulsion was centrifuged (10 min, 4000xg, 4°C). After removing the hexane layer, the methanol-water part was vacuum-filtered through Whatman N° 3 paper and the resultant filtrate was extracted with two 60-mL volumes of chloroform. The two chloroform extracts from each portion were pooled, added with 10 g anhydrous Na~2~SO~4~ (J.T.Baker Chemicals) and evaporated to dryness using a rotary evaporator at 37°C. The dried extract was dissolved with chloroform and cleaned up by a LiChrolut SPE Si 2024 silica gel column (Merck) eluted with 2 mL of mixture of hexane and ethyl acetate (J.T.Baker Chemicals). The residues were reduce to dryness under gentle nitrogen stream and dissolved in 100 μL of CHC1~3~ (Siemens and Zawistowski, [@ref46]). For roquefortine C: a 50 g portion of cheese was homogenised with 10 g of celite (J.T.Baker Chemicals) and 250 mL of ethyl acetate in an waring blender for 5 min at high speed. The extract was filtred throught Whatman N°. 1 paper and added with 50 mL of HCl (0.01 N) (J.T.Baker Chemicals). After a gentle agitation fo 20 sec, the watery phase was recovered and the organic phase was extracted a second time with 50 mL of acid solution. The two extract were defatted with 50 mL of hexane. At the watery phase was addeded 50 mL of 3% NaHCO~3~ (Merck) and it was extracted twice with 50 mL of ethyl acetate. At the two organic phases were addeded with 10 g of 10 g anhydrous Na~2~SO~4~ (J.T.Baker Chemicals), shaked for 10' and evaporated to dryness using a rotary evaporator at 37°C. The dried extract was dissolved with chloroform, reduce to dryness under gentle nitrogen stream and dissolved in 100 μL of CHC1~3~ (Ware *et al*., [@ref50]).

The analysis was performed in HPLC with diode array detection (Hplc and diode-arrays detector system; Shimadzu). The column was a 100 mm x 4 mm I.D. Nucleosil 5 μm C~18~ column (Waters Corporation). All the reagents were Hplc grade. The extracted metabolites were finally detected by following the above-mentioned method (Frisvad and Thrane, [@ref16]). The analyses were performed in duplicate.

Results {#sec1-4}
=======

Step A: *in* *vitro* research {#sec2-9}
-----------------------------

As regards the strains analysed *in vitro*, only two strains out of nine produced Roquefortine C (NON 10803 and PY 10604). Mycophenolic acid was drawn out from four strains (NON 10803; NON 11203; NON 10804; NOPC 09103); PR toxin was not detected in any of the strains analysed in our study.

Step B: research on bread-like samples {#sec2-10}
--------------------------------------

In this stage of the study, there was no evidence of the production of metabolites from the *Penicillium* tested. The substratum breadlike may not have had right characteristics to allow or support the production of mycotoxins from these moulds.

Step C: *in* *vivo* research {#sec2-11}
----------------------------

Secondary metabolites were not detected in any of the cheese samples analysed, although we applied metabolite-specific methodologies.

Discussion {#sec1-5}
==========

The results of the analyses indicate that the strains of *Penicillium roqueforti* tested were only able to produce secondary metabolites *in vitro*. Roquefortine C and mycophenolic acid are the only secondary metabolites that the strains of *Penicillium roqueforti* tested produced in culture, in agreement with O'Brien *et al*. ([@ref31]) and Fog Nielsen *et al*. ([@ref13]), only on CYA medium. Our *in vivo* tests produced no positive results. The qualitative and quantitative mycotoxin profile, which a mould produces on a food commodity, really depends on the ecological and processing parameters of the particular foodstuff (Filtenborg *et al*., [@ref11]) and can therefore be expected to be different from synthetic media.

The *Penicillium roqueforti* studied are very easily developed on the industrial culture medium bread-like (CSL Laboratory uses this substratum bread-like for the growth of the *P. roqueforti* and to produce suspensions of spores). Due to its resistance to organic acids and ability to grow at low pH, *P. roqueforti* is found as a contaminant of processed food such as bread, rye bread (Fog Nielsen *et al*., [@ref13]), even if the dominant spoilage flora varies with the type of bread and the storage temperature. Mycotoxigenic moulds can be isolated from spoiled breads, and many mycotoxins have been produced in inoculated breads, but naturally the toxins are mainly aflatoxins, ochratoxin A, *Fusarium* toxins.

On cheese's samples too, our research did not provide any results: the strains of *Penicillium* tested did not produce secondary metabolites. Similar results have been obtained by several authors, who observed that mould strains grown in cheese did not produce metabolites even though they belonged to potentially toxigenic species. Note that the production of secondary metabolites from moulds is a strain specific characteristic, and toxigenic strains cannot be differentiated from non-toxigenic strains by morphological characteristic alone. Therefore, a fungal species is referred to as *potentially toxigenic*, which indicates that some strains may produce toxic metabolites. Indeed, in order to test the presence or absence of secondary metabolites in a food sample, it is essential to let the strains grow under suitable conditions. In fact, the production of mycotoxins depends on the substrate, which is particularly important for the mould strains used in food production (Scott and Kanhere, [@ref44]). In reality, the strains tested in this study behaved differently in laboratory medium, in industrial medium and in cheese.

Additionally, toxigenic moulds are believed to represent a minor proportion of the total flora in cheese and cheese factory environments: the fungal metabolism is affected by environmental factors such as temperature, water activity, pH, substrate, strains of moulds, gas composition, microbial interactions (competitive bacterial or other fungal species). Several experiments applying techniques of molecular biology have investigated the influence of these parameters on the expression of mycotoxin biosynthesis genes and have shown that the effect of external factors on mycotoxin biosynthesis is exerted at the level of transcription (Schmidt-Heydt *et al*., [@ref39]). As expected, PR-toxin was not detected in cheese because of its reactivity with nitrogen compounds, as previously described. Indeed, cheese is not necessarily a good substrate for mycotoxin formation and some mycotoxins (like penicillic acid and PR toxins) have been shown to be unstable in the cheese matrix (Kokkonen *et al*., [@ref23]; Boysen *et al*., [@ref3]).

Regarding roquefortine C, our results differ from similar research: Kokkonen *et al*. ([@ref23]) detected this metabolite in all the ten cheese samples analysed, with quantities ranging from 0.8 to 12 μg/kg. Similar results were obtained by Schoch *et al*. ([@ref40], [@ref41]) and Finoli *et al*. ([@ref12]). On the other hand, our results are in agreement with other studies show that strains of *Penicillium roqueforti* isolated from cheeses produced only PR toxin and penicillic acid (Van Egmond, [@ref49]), or only patulin and penicillic acid (Wei Yun *et al*., [@ref52]). The production of roquefortin C seems to be influenced by many factors including the amount of NaCl in the substrate, the ripening time of the cheese and the intervals between the punctures (usually after 20-30 days), because an increasing puncturing rate introduces more oxygen into the cheese to help the growth of moulds.

Conclusions {#sec1-6}
===========

In order to reduce the presence of secondary metabolites in blue cheeses, one of the methods suggested by several authors is the use of strain with low productive ability (Engel and Teuber, [@ref8]; Moss, [@ref29]; Lafont *et al*., [@ref27]; Pose *et al*., [@ref36]). Buzilova *et al*. ([@ref4]) have studied the effect of mutation on synthesis of alkaloid by *Penicillium roquefortii* VKM F-141. The study has shown that the Penicilli mutants were unable to synthesise alkaloids or they changed the alkaloid composition. Puel *et al*. ([@ref37]) have shown that the ability to produce patulin from *Byssochlamys fulva* is related to presence/absence of two genes.

The latest techniques of molecular biology should be used to detoxify foods by secondary metabolites, identifying and removing genes responsible for the mycotoxin synthesis, in order to prevent its production (Gigliotti and Verga, [@ref17]). Currently this is only possible for some secondary metabolites but in our opinion these techniques could be transferred to other species. This will be possible only through a more extensive understanding of fungal genomes.
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